SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-053598
Filing Date
2024-05-06
Accepted
2024-05-06 16:30:35
Documents
52
Period of Report
2024-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dawn-20240506.htm   iXBRL 8-K 46735
2 EX-99.1 dawn-ex99_1.htm EX-99.1 75819
3 EX-99.2 dawn-ex99_2.htm EX-99.2 44847
4 GRAPHIC img109617361_0.jpg GRAPHIC 9664
5 GRAPHIC dawn-ex99_2s1.jpg GRAPHIC 215296
6 GRAPHIC dawn-ex99_2s2.jpg GRAPHIC 686653
7 GRAPHIC dawn-ex99_2s3.jpg GRAPHIC 415033
8 GRAPHIC dawn-ex99_2s4.jpg GRAPHIC 315512
9 GRAPHIC dawn-ex99_2s5.jpg GRAPHIC 250469
10 GRAPHIC dawn-ex99_2s6.jpg GRAPHIC 291331
11 GRAPHIC dawn-ex99_2s7.jpg GRAPHIC 486582
12 GRAPHIC dawn-ex99_2s8.jpg GRAPHIC 368895
13 GRAPHIC dawn-ex99_2s9.jpg GRAPHIC 428850
14 GRAPHIC dawn-ex99_2s10.jpg GRAPHIC 356232
15 GRAPHIC dawn-ex99_2s11.jpg GRAPHIC 357917
16 GRAPHIC dawn-ex99_2s12.jpg GRAPHIC 332884
17 GRAPHIC dawn-ex99_2s13.jpg GRAPHIC 507077
18 GRAPHIC dawn-ex99_2s14.jpg GRAPHIC 287788
19 GRAPHIC dawn-ex99_2s15.jpg GRAPHIC 345135
20 GRAPHIC dawn-ex99_2s16.jpg GRAPHIC 317353
21 GRAPHIC dawn-ex99_2s17.jpg GRAPHIC 294691
22 GRAPHIC dawn-ex99_2s18.jpg GRAPHIC 309413
23 GRAPHIC dawn-ex99_2s19.jpg GRAPHIC 204617
24 GRAPHIC dawn-ex99_2s20.jpg GRAPHIC 388089
25 GRAPHIC dawn-ex99_2s21.jpg GRAPHIC 242550
26 GRAPHIC dawn-ex99_2s22.jpg GRAPHIC 537138
27 GRAPHIC dawn-ex99_2s23.jpg GRAPHIC 431905
28 GRAPHIC dawn-ex99_2s24.jpg GRAPHIC 375167
29 GRAPHIC dawn-ex99_2s25.jpg GRAPHIC 103436
30 GRAPHIC dawn-ex99_2s26.jpg GRAPHIC 302736
31 GRAPHIC dawn-ex99_2s27.jpg GRAPHIC 341613
32 GRAPHIC dawn-ex99_2s28.jpg GRAPHIC 342502
33 GRAPHIC dawn-ex99_2s29.jpg GRAPHIC 357497
34 GRAPHIC dawn-ex99_2s30.jpg GRAPHIC 413117
35 GRAPHIC dawn-ex99_2s31.jpg GRAPHIC 266967
36 GRAPHIC dawn-ex99_2s32.jpg GRAPHIC 313061
37 GRAPHIC dawn-ex99_2s33.jpg GRAPHIC 468865
38 GRAPHIC dawn-ex99_2s34.jpg GRAPHIC 427013
39 GRAPHIC dawn-ex99_2s35.jpg GRAPHIC 418028
40 GRAPHIC dawn-ex99_2s36.jpg GRAPHIC 427381
41 GRAPHIC dawn-ex99_2s37.jpg GRAPHIC 399209
42 GRAPHIC dawn-ex99_2s38.jpg GRAPHIC 391492
  Complete submission text file 0000950170-24-053598.txt   19211326

Data Files

Seq Description Document Type Size
43 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dawn-20240506.xsd EX-101.SCH 23892
55 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20240506_htm.xml XML 4552
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 24918002
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)